Skip to main content

Russell Investments Group, Ltd.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in HALO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$19,446,722
+$2,581,791 QoQ
Shares Held
248,457
-4.8% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#85
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 75% Shared 0% None 25%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. HALO ranks #21 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,446,722 248,457
2026-03-31 $16,864,931 260,946
2025-12-31 $20,715,270 307,805
2025-09-30 $22,412,477 305,597
2025-06-30 $13,558,589 260,642
2025-03-31 $3,109,905 48,737
2024-12-31 $1,747,739 36,556
2024-09-30 $18,281,307 319,380
2024-06-30 $21,482,466 410,284
2024-03-31 $12,145,012 298,550
2023-12-31 $13,294,730 359,706
2023-09-30 $16,146,832 422,692
2023-06-30 $6,276,141 173,999
2023-03-31 $7,902,425 206,924
2022-12-31 $13,778,845 242,159
2022-09-30 $10,712,215 270,921
2022-06-30 $12,013,232 273,028
2022-03-31 $6,437,867 161,431
2021-12-31 $2,733,956 67,992
2021-09-30 $3,098,432 76,166
2021-06-30 $4,094,845 90,175
2021-03-31 $8,949,466 214,667
2020-12-31 $8,320,889 194,823
2020-09-30 $5,269,899 200,529
2020-06-30 $4,483,113 167,218
2020-03-31 $2,388,117 132,747